Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 99 | 2 | 101 | +4 |
| Shares | 31.4M | 3.31M | 32.8M | +4.75M (+16.9%) |
| Value | $54.6M | $5.77M | $36.1M | −$12.7M (−26.0%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jupiter Topco LLC | 5,171,053 | $5.71M | 0.00% |
| Caption Management, LLC | 478,950 | $526.8K | 0.02% |
| Quadrature Capital Ltd | 258,928 | $284.8K | 0.00% |
| Nomura Holdings Inc | 150,000 | $165.0K | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 133,648 | $147.0K | 0.00% |
| Invesco Ltd. | 80,338 | $88.4K | 0.00% |
| Engineers Gate Manager LP | 33,691 | $37.1K | 0.00% |
| Headlands Technologies LLC | 29,889 | $32.9K | 0.00% |
| Zacks Investment Management | 26,435 | $29.1K | 0.00% |
| StoneX Group Inc. | 14,252 | $18.1K | 0.00% |
| Two Sigma Securities, LLC | 15,958 | $17.6K | 0.00% |
| Axq Capital, LP | 13,863 | $15.2K | 0.00% |
| Optiver Holding B.V. | 1,325 | $1.46K | 0.00% |
| IFG Advisory, LLC | 833 | $917 | 0.00% |
| Aberdeen Wealth Management LLC | 200 | $220 | 0.00% |
| Decker Retirement Planning Inc. | 168 | $185 | 0.00% |
| SRS Capital Advisors, Inc. | 103 | $113 | 0.00% |
| McDonald Partners LLC | 58 | $64 | 0.00% |
| Allied Private Wealth LLC | 33 | $39 | 0.00% |
| Valley National Advisers Inc | 24 | $27 | 0.00% |
| Northwestern Mutual Wealth Management Co | 8 | $9 | 0.00% |
| Strive Financial Group ,LLC | 1 | $1 | 0.00% |
Sold out (18)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 804,958 | $1.40M |
| Diadema Partners LP | 562,665 | $979.0K |
| 683 Capital Management, LLC | 248,790 | $432.9K |
| Persistent Asset Partners Ltd | 142,164 | $247.4K |
| Susquehanna International Group, LLP | 56,862 | $98.9K |
| CIBC Bancorp USA Inc. | 50,000 | $87.0K |
| IMC-Chicago, LLC | 37,889 | $65.9K |
| Bank of America Corp | 32,677 | $56.9K |
| Nine Masts Capital Ltd | 26,317 | $45.8K |
| Diametric Capital, LP | 24,491 | $42.6K |
| Qube Research & Technologies Ltd | 14,651 | $25.5K |
| Marshall Wace, LLP | 13,187 | $22.9K |
| Legacy Wealth Managment, LLC | 1,356 | $2.36K |
| MAI Capital Management | 830 | $1.45K |
| Rhumbline Advisers | 602 | $1.05K |
| Clearstead Advisors, LLC | 500 | $870 |
| Root Financial Partners, LLC | 208 | $362 |
| HM Payson & Co | 2 | $4 |
Not filed for Q2 2026 yet (2)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 3,308,406 | $5.77M |
| CWM, LLC | 146 | $254 |